Search by Drug Name or NDC
NDC 69315-0284-01 ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE 1.25; 2.5 mg/1; mg/1 Details
ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE 1.25; 2.5 mg/1; mg/1
ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Leading Pharmaceuticals, LLC. The primary component is ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE.
Product Information
| NDC | 69315-0284 |
|---|---|
| Product ID | 69315-284_b0329bda-d477-4eed-815c-1049532e1bb0 |
| Associated GPIs | |
| GCN Sequence Number | 003258 |
| GCN Sequence Number Description | estrogen,ester/me-testosterone TABLET 1.25-2.5MG ORAL |
| HIC3 | G1B |
| HIC3 Description | ESTROGEN/ANDROGEN COMBINATIONS |
| GCN | 68031 |
| HICL Sequence Number | 001438 |
| HICL Sequence Number Description | ESTROGENS,ESTERIFIED/METHYLTESTOSTERONE |
| Brand/Generic | Generic |
| Proprietary Name | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ESTERIFIED ESTROGENS, METHYLTESTOSTERONE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 1.25; 2.5 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE |
| Labeler Name | Leading Pharmaceuticals, LLC |
| Pharmaceutical Class | Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS] |
| DEA Schedule | CIII |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2025-12-31 |
Package
NDC 69315-0284-01 (69315028401)
| NDC Package Code | 69315-284-01 |
|---|---|
| Billing NDC | 69315028401 |
| Package | 100 TABLET in 1 BOTTLE (69315-284-01) |
| Marketing Start Date | 2022-10-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |